(SULBACTAM & CEFOTAXIME FOR INJECTION)
Each vial contains:
Sulbactam Sodium USP
equivalent to Sulbactam 0.5g
Cefotaxime Sodium USP
equivalent to Cefotaxime 1g
- Lower Respiratory Tract Infections
- Gastro-intestinal Tract Infections
- Genito Urinary Tract Infections
- Gynaecological Infections
- Skin and Skin structure Infections
- Intra-Abdominal Infections
- Bone and joint infections
- Central nervous system infections
Adult: Mild to moderate: 1/0.5 to 2/1g of cefotaxime/sulbactam every 8-12 hours.
Moderate to severe: 1/0.5 to 2/1g of cefotaxime/sulbactam every 6-8 hours.
Children: 100/50 to 150/75mg of cefotaxime/sulbactam per kg b.w.per day in three divided doses.
Zitax is contraindicated in patients who have shown hypersensitivity to cefotaxime sodium or the cephalosporin group of antibiotics.
USE IN PREGNANCY
Teratogenic effects were not observed in animal studies; therefore, cefotaxime is classified as pregnancy category B. Cefotaxime crosses the placenta and can be found in fetal tissue. An increased risk of teratogenic effects has not been observed following maternal use. During pregnancy, peak cefotaxime serum concentrations are decreased and the serum half-life is shorter.
Enters breast milk use with caution
Local Reactions: Deep phlebitis after IV injection has been reported.
General Reaction: Skin eruptions, fever, eosinophilia, neutropenia, transient leucopenia and haemolytic anaemia.
ZITAX must be used with caution in penicillin-sensitive subjects. Strict medical supervision is required throughout the treatment.
DIRECTION FOR RECONSTITUTION
Dissolve the content in 5ml Sterilised Water for injection BP (SWFI) for IM use and in 10ml for IV use. Use the reconstituted solution immediately after preparation.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Treatment should be symptomatic and supportive. In case of overdose, especially in renal impairment, there is a risk of reversible metabolic encephalopathy.
Available as dry powder of 1.5g in a Vial with 10 ml Sterilised Water for Injection BP
Store in a cool dry place, protected from light.
Keep out of reach of children
Myanmar Reg.NO: 1609AA3392
Galpha Laboratories Limited
At: Village Thana, Baddi,
Himachal Pradesh 173 205. INDIA
Zifam Pinnacle Pty Ltd,
The Healthcare Group